Terence Flynn
Stock Analyst at Morgan Stanley
(4.71)
# 839
Out of 5,073 analysts
1102
Total ratings
59.7%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Maintained: Hold | $23 | $23.75 | -3.16% | 17 | Oct 21, 2026 | |
| BNTX BioNTech SE | Rated: Buy | $114 | $91.17 | +25.04% | 97 | Oct 19, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $294 → $292 | $259.36 | +12.58% | 60 | Oct 15, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $38 | $26.10 | +45.59% | 19 | Oct 15, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Sell | $41 | $61.68 | -33.53% | 53 | Oct 12, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,419 → $1,430 | $1,283.66 | +11.40% | 81 | Oct 9, 2026 | |
| ABBV AbbVie | Rated: Buy | $296 → $310 | $289.08 | +7.24% | 55 | Oct 7, 2026 | |
| AMGN Amgen | Reiterated: Hold | $362 → $359 | $438.94 | -18.21% | 58 | Oct 7, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $165 → $163 | $156.51 | +4.15% | 64 | Oct 7, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $179 → $177 | $148.30 | +19.35% | 58 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 → $95 | $242.08 | -60.76% | 38 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 | $30.11 | -7.01% | 61 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $758 → $779 | $807.48 | -3.53% | 61 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $67 | $62.25 | +7.63% | 31 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $515 → $566 | $553.88 | +2.19% | 35 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $665 | $514.65 | +29.21% | 56 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $29 | $6.70 | +332.84% | 11 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $11.81 | +60.88% | 19 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $19.01 | +152.50% | 8 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $11 → $10 | $7.66 | +30.55% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $126 | $22.88 | +450.70% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 | $11.84 | +26.69% | 19 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.92 | - | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $222 → $231 | $243.10 | -4.98% | 62 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $13.76 | -34.59% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $33 | $49.88 | -33.84% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.16 | n/a | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.58 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $16 | $44.11 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $12 | $2.51 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €93.50 | €146.40 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $42.64 | $9.01 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $78.75 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $163 → $155 | $230.71 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $83.17 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $5.28 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $36.64 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $9.16 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $2.31 | n/a | 1 | Jul 21, 2015 |
Arcus Biosciences
Oct 21, 2026
Maintained: Hold
Price Target: $23
Current: $23.75
Upside: -3.16%
BioNTech SE
Oct 19, 2026
Rated: Buy
Price Target: $114
Current: $91.17
Upside: +25.04%
Johnson & Johnson
Oct 15, 2026
Rated: Buy
Price Target: $294 → $292
Current: $259.36
Upside: +12.58%
Nurix Therapeutics
Oct 15, 2026
Reiterated: Buy
Price Target: $38
Current: $26.10
Upside: +45.59%
Bristol-Myers Squibb Company
Oct 12, 2026
Reiterated: Sell
Price Target: $41
Current: $61.68
Upside: -33.53%
Eli Lilly and Company
Oct 9, 2026
Reiterated: Buy
Price Target: $1,419 → $1,430
Current: $1,283.66
Upside: +11.40%
AbbVie
Oct 7, 2026
Rated: Buy
Price Target: $296 → $310
Current: $289.08
Upside: +7.24%
Amgen
Oct 7, 2026
Reiterated: Hold
Price Target: $362 → $359
Current: $438.94
Upside: -18.21%
Gilead Sciences
Oct 7, 2026
Reiterated: Buy
Price Target: $165 → $163
Current: $156.51
Upside: +4.15%
Merck & Co.
Oct 7, 2026
Reiterated: Buy
Price Target: $179 → $177
Current: $148.30
Upside: +19.35%
Oct 7, 2026
Rated: Hold
Price Target: $89 → $95
Current: $242.08
Upside: -60.76%
Oct 7, 2026
Rated: Hold
Price Target: $28
Current: $30.11
Upside: -7.01%
Oct 7, 2026
Reiterated: Hold
Price Target: $758 → $779
Current: $807.48
Upside: -3.53%
Oct 7, 2026
Reiterated: Buy
Price Target: $65 → $67
Current: $62.25
Upside: +7.63%
Oct 7, 2026
Reiterated: Hold
Price Target: $515 → $566
Current: $553.88
Upside: +2.19%
Oct 7, 2026
Rated: Buy
Price Target: $665
Current: $514.65
Upside: +29.21%
Sep 2, 2026
Reiterated: Buy
Price Target: $39 → $29
Current: $6.70
Upside: +332.84%
Aug 12, 2026
Reiterated: Buy
Price Target: $18 → $19
Current: $11.81
Upside: +60.88%
Aug 12, 2026
Reiterated: Buy
Price Target: $48
Current: $19.01
Upside: +152.50%
Aug 10, 2026
Rated: Hold
Price Target: $11 → $10
Current: $7.66
Upside: +30.55%
Aug 10, 2026
Rated: Buy
Price Target: $126
Current: $22.88
Upside: +450.70%
Aug 10, 2026
Rated: Hold
Price Target: $15
Current: $11.84
Upside: +26.69%
Aug 10, 2026
Rated: Hold
Price Target: n/a
Current: $3.92
Upside: -
Jul 30, 2026
Reiterated: Hold
Price Target: $222 → $231
Current: $243.10
Upside: -4.98%
Apr 10, 2026
Reiterated: Hold
Price Target: $9
Current: $13.76
Upside: -34.59%
Feb 17, 2026
Reiterated: Sell
Price Target: $32 → $33
Current: $49.88
Upside: -33.84%
Sep 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.16
Upside: n/a
Dec 13, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.58
Upside: n/a
Jun 1, 2021
Reiterated: Sell
Price Target: $16
Current: $44.11
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $21 → $12
Current: $2.51
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €93.50
Current: €146.40
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $42.64
Current: $9.01
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $78.75
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $163 → $155
Current: $230.71
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $83.17
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $5.28
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $46
Current: $36.64
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $9.16
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $2.31
Upside: n/a